NO146600C - Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater - Google Patents
Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivaterInfo
- Publication number
- NO146600C NO146600C NO774101A NO774101A NO146600C NO 146600 C NO146600 C NO 146600C NO 774101 A NO774101 A NO 774101A NO 774101 A NO774101 A NO 774101A NO 146600 C NO146600 C NO 146600C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- therapeutic active
- analogy procedure
- imidazold
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/74—Naphthothiophenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
- C07C2603/26—Phenanthrenes; Hydrogenated phenanthrenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LU76303 | 1976-12-01 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO774101L NO774101L (no) | 1978-06-02 |
| NO146600B NO146600B (no) | 1982-07-26 |
| NO146600C true NO146600C (no) | 1982-11-03 |
Family
ID=19728422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO774101A NO146600C (no) | 1976-12-01 | 1977-11-30 | Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4171366A (de) |
| JP (1) | JPS5368776A (de) |
| AT (1) | AT361469B (de) |
| AU (1) | AU517512B2 (de) |
| BE (1) | BE861337A (de) |
| CA (1) | CA1097351A (de) |
| DE (1) | DE2753054A1 (de) |
| DK (1) | DK531977A (de) |
| ES (1) | ES464611A1 (de) |
| FI (1) | FI773593A (de) |
| FR (1) | FR2372829A1 (de) |
| GB (1) | GB1590648A (de) |
| NL (1) | NL7713241A (de) |
| NO (1) | NO146600C (de) |
| NZ (1) | NZ185824A (de) |
| SE (1) | SE7713574L (de) |
| ZA (1) | ZA777129B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL8003141A (nl) * | 1980-05-30 | 1982-01-04 | Akzo Nv | Biologisch aktieve tricyclische aminen. |
| GB8726505D0 (en) * | 1987-11-12 | 1987-12-16 | Ici Plc | Naphtho(2 1-b)furan derivatives |
| EP0336759A1 (de) * | 1988-04-07 | 1989-10-11 | Glaxo Group Limited | Imidazol-Derivate |
| GB9407919D0 (en) * | 1994-04-21 | 1994-06-15 | Glaxo Group Ltd | Chemical compounds |
| WO2011049704A1 (en) * | 2009-10-22 | 2011-04-28 | The University Of North Carolina At Chapel Hill | Antofine and cryptopleurine derivatives as anticancer agents |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3903092A (en) * | 1966-03-02 | 1975-09-02 | Aspro Nicholas Ltd | 2-Tertiaryamino-1-(benzo{8 b{9 thienyl)ethanols |
| SE7600674L (sv) * | 1975-02-05 | 1976-08-06 | Rohm & Haas | Fungicider |
-
1977
- 1977-11-24 GB GB48953/77A patent/GB1590648A/en not_active Expired
- 1977-11-25 US US05/854,935 patent/US4171366A/en not_active Expired - Lifetime
- 1977-11-28 FI FI773593A patent/FI773593A/fi not_active Application Discontinuation
- 1977-11-28 DE DE19772753054 patent/DE2753054A1/de not_active Withdrawn
- 1977-11-28 FR FR7735727A patent/FR2372829A1/fr active Granted
- 1977-11-29 CA CA291,993A patent/CA1097351A/en not_active Expired
- 1977-11-30 NZ NZ185824A patent/NZ185824A/xx unknown
- 1977-11-30 AU AU31087/77A patent/AU517512B2/en not_active Expired
- 1977-11-30 BE BE183038A patent/BE861337A/xx unknown
- 1977-11-30 ES ES464611A patent/ES464611A1/es not_active Expired
- 1977-11-30 NL NL7713241A patent/NL7713241A/xx not_active Application Discontinuation
- 1977-11-30 NO NO774101A patent/NO146600C/no unknown
- 1977-11-30 DK DK531977A patent/DK531977A/da unknown
- 1977-11-30 ZA ZA00777129A patent/ZA777129B/xx unknown
- 1977-11-30 SE SE7713574A patent/SE7713574L/xx not_active Application Discontinuation
- 1977-11-30 AT AT857177A patent/AT361469B/de not_active IP Right Cessation
- 1977-12-01 JP JP14334377A patent/JPS5368776A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AT361469B (de) | 1981-03-10 |
| NL7713241A (de) | 1978-06-05 |
| FR2372829A1 (fr) | 1978-06-30 |
| BE861337A (fr) | 1978-05-30 |
| AU517512B2 (en) | 1981-08-06 |
| NO146600B (no) | 1982-07-26 |
| CA1097351A (en) | 1981-03-10 |
| GB1590648A (en) | 1981-06-03 |
| ZA777129B (en) | 1978-09-27 |
| DE2753054A1 (de) | 1978-06-08 |
| ATA857177A (de) | 1980-08-15 |
| US4171366A (en) | 1979-10-16 |
| ES464611A1 (es) | 1978-09-01 |
| NZ185824A (en) | 1980-08-26 |
| NO774101L (no) | 1978-06-02 |
| FI773593A (fi) | 1978-06-02 |
| SE7713574L (sv) | 1978-06-02 |
| DK531977A (da) | 1978-06-02 |
| JPS5368776A (en) | 1978-06-19 |
| FR2372829B1 (de) | 1982-06-04 |
| AU3108777A (en) | 1979-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO147243C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater | |
| NO149586C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive polypeptider | |
| NO151321C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater | |
| NO151463C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater | |
| NO148148C (no) | Fremgangsmaate til fremstilling av terapeutisk aktive 4-hydroksy-2-pyrrolidinonderivater | |
| NO151411C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater | |
| NO148453C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive spirohydantoinderivater | |
| NO800881L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater | |
| NO144848C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme 4-hydroksyfenylalkanolamin-derivater | |
| NO148777C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive antrakinon-derivater | |
| NO150044C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrazol-derivater | |
| NO145198C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktivt 1,2-benzisotia-zolinon-3 | |
| NO149313C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner | |
| NO145951C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolinderivater | |
| NO149037C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner | |
| NO148291C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive basisk substituerte teofyllinderivater | |
| NO148488C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive acyl-benzimidazol-2-derivater | |
| NO145163C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive antitumorglykosider | |
| NO151660C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater. | |
| NO143903C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-fluorpyrimidin-4-on-derivater | |
| NO780644L (no) | Fremgangsmaate til fremstilling av terapeutisk virksomme 9-hydroksyetoksymetylguanin-derivater | |
| NO152172C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-kinolyl-hydantoin-derivater | |
| NO146600C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater | |
| NO147273C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive cykloheksadien-derivater | |
| NO152556C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive antracen-biskarbonylhydrazoner |